Serum and bronchoalveolar lavage fluid neopterin levels in patients with bronchial asthma (preliminary report);Stȩżenia neopteryny w surowicy i popłuczynach oskrzelowo-pȩcherzykowych u chorych na astmȩ oskrzelowa̧ (doniesienie wstȩpne)

Polski Merkuriusz Lekarski

Volumn 14, Issue 79, 2003, Pages 28-30

  Passowicz Muszyńska, Ewa ^a   Krasnowska, Maryla ^a   Jankowska, Renata ^a   Piesiak, Paweł ^a   Malepszy J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

BALF; Bronchial asthma; Bronchoalveolar lavage fluid; Neopterin

Indexed keywords

NEOPTERIN;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; LUNG LAVAGE; ADULT; BLOOD; CHEMISTRY; ENZYMOLOGY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; TIME;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; NEOPTERIN; TIME FACTORS;

EID: 0037805728     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barnes P.J.: Pathophysiology of asthma. Br. J. Clin. Pharmacol., 1996, 42, 3-10.
2. Bernstein I.L. i wsp.: Summary and recomendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. Am. Rev. Resp. Dis., 1985, 132, 180.
3. Blaschke E. i wsp.: Relationship between serum neopterin and lymohocytic alveolitis in sarcoidosis. Sarcoidosis, 1988, 5, 25-30.
4. Blau N. i wsp.: Biosynthesis and significance of neopterin in the immune system. Eur. J. Cancer Clin. Oncol., 1989, 25, 603-605.
5. Dhondt J.L. i wsp.: Unconjugated pteridines in bronchoalveolar lavage as indicators of alveolar macrophage activation. Chest, 1989, 95, 348-351.
6. Eklund A. i wsp.: Elevated serum neopterin levels in sarcoidosis. Lung, 1986, 164, 325-332.
7. Fuchs D. i wsp.: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int. Arch. Allergy Immunol., 1993, 101, 1-6.
8. Fuchs D. i wsp.: The role of neopterin as a monitor of cellular immune activation in transplantation, inflammation, infections and malignant diseases. Crit. Rev. Clin. Lab. Sci., 1992, 29, 307-341.
9. Gruber A. i wsp.: Histamine supresses neopterin production in human myelomonocytoma cell line THP-1. Immunol. Lett., 2000, 1, 72, 2. 133-136.
10. Howell C.J. i wsp.: Identification of an alveolar macrophage derived activity in bronchial asthma which enchances leukotriene C4 generation by human eosinophils stimulated by ionophore as granulocyte macrophage colony stimulating factor (GM-CSF). Am. Rev. Respir. Dis., 1987, 136, 1340-1347.
11. Huber C. i wsp.: Immune response-associated production of neopterin. J. Exp. Med., 1984, 160, 31-316.
12. Jakóbisiak M.: Immunologia. PWN. Warszawa. 1998.
13. Jeffrey P.: Structural an inflammatory changes in COPD: a comparison with asthma. Thorax, 1998, 9, 129-136.
14. Joseph M. i wsp.: The interaction of IgE antibody with human alveolar macrophages and its participation in the inflammatory processes of lung allergy. Agents Actions, 1981, 11, 619-622.
15. Joseph M. i wsp.: Involvement of immunoglobulin E in the secretory processes of alveolar macrophages of asthmatic patients. J. Clin. Invest., 1983, 71, 221-230.
16. Lane S. J. i wsp.: The role of the macrophage in asthma. Allergy, 1994, 49, 201-209.
17. Lee T.H. i wsp.: The role of macrophages in the mechanisms of airway inflammation in asthma. Am. Rev. Respir. Dis., 1992, 145, 27-30.
18. Menz G. i wsp.: Neopterin in phases of exacerbation of bronchial asthma and in experimental asthma conditions. Pneumonologie, 1990, 44, suppl. 1, 232-233.
19. Milanowski J.: Significance of alveolar macrophages in the allergic reactions of the lung. Int. Rev. Allergol. Clin. Immunol., 1995, 4, 1-4.
20. Neale T.J. i wsp.: Neopterin quantification in acute severe asthma. Clin. Exp. Allergy, 1991, 21, 4, 417-424.
21. Romagnoli M. i wsp.: Difficult asthma and chronic obstructive pulmonary disease (COPD) similarites and discrepancies. In: Difficult asthma. Holgate S.T., Boushey H.A., Fabbri L.M. Publ. MSD Martin Dunitz. Londyn. 1999.
22. Saito M. i wsp.: Elevated local production of neopterin from alveolar macrophages in patients with internal lung diseases. Gen. Pharmac., 1996, 27, 483-486.
23. Tilz G.P. i wsp.: Increased immune activation during and after physical exercise. Immunobiology, 1993, 188, 1-2, 194-202.
24. Venet A. i wsp.: Enhanced alveolar macrophage-mediated antigen-induced T lymphocyte proliferation in sarcoidosis. J. Clin. Invest., 1985, 75, 293-301.